Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
McDonald's
MCD
|
+$376M |
| 2 |
Apple
AAPL
|
+$264M |
| 3 |
STJ
St Jude Medical
STJ
|
+$263M |
| 4 |
Microsoft
MSFT
|
+$260M |
| 5 |
Alibaba
BABA
|
+$172M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995M |
| 2 |
CAM
CAMERON INTERNATIONAL CORPORATION
CAM
|
+$261M |
| 3 |
Gilead Sciences
GILD
|
+$247M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$232M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$214M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.56% |
| 2 | Healthcare | 4.73% |
| 3 | Financials | 4.3% |
| 4 | Consumer Discretionary | 3.31% |
| 5 | Energy | 2.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4851
CALL
iShares MSCI Italy ETF
EWI
$1.05B
| $40K | ﹤0.01% |
1,850
-200
| -10% | -$4.77K |
|
4852
HNI Corp
HNI
$3.42B
| $40K | ﹤0.01% |
851
+384
| +82% | +$16.8K |
|
4853
PUT
JB Hunt Transport Services
JBHT
$25.4B
| $40K | ﹤0.01% |
500
-1,400
| -74% | -$116K |
|
4854
PUT
Northern Trust
NTRS
$33B
| $40K | ﹤0.01% |
600
-1,400
| -70% | -$97.5K |
|
4855
PDS Biotechnology
PDSB
$39.2M
| $40K | ﹤0.01% |
+199
| New | +$35.2K |
|
4856
CALL
Ribbon Communications
RBBN
$373M
| $40K | ﹤0.01% |
4,600
+2,900
| +171% | +$24.2K |
|
4857
Tronox
TROX
$930M
| $40K | ﹤0.01% |
9,036
-1,975,707
| -100% | -$11.2M |
|
|
TRUE
4858
DELISTED
TrueCar
TRUE
| $40K | ﹤0.01% |
5,058
+4,806
| +1,907% | +$31.9K |
|
|
UNIT
4859
CALL
Uniti Group
UNIT
$2.36B
| $40K | ﹤0.01% |
1,380
| – | – |
|
|
MN
4860
DELISTED
MANNING & NAPIER, INC.
MN
| $40K | ﹤0.01% |
+4,176
| New | +$36.7K |
|
|
GBT
4861
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $40K | ﹤0.01% |
+2,410
| New | +$48.6K |
|
|
KOL
4862
CALL
DELISTED
VanEck Vectors Coal ETF
KOL
| $40K | ﹤0.01% |
430
+380
| +760% | +$31.4K |
|
|
BBG
4863
PUT
DELISTED
Bill Barrett Corp
BBG
| $40K | ﹤0.01% |
6,300
-1,900
| -23% | -$13.9K |
|
|
CAVM
4864
DELISTED
Cavium, Inc.
CAVM
| $40K | ﹤0.01% |
1,033
-17,891
| -95% | -$885K |
|
4865
Arrowhead Research
ARWR
$11.9B
| $39K | ﹤0.01% |
7,560
-2,160
| -22% | -$12.3K |
|
4866
PUT
Four Corners Property Trust
FCPT
$2.79B
| $39K | ﹤0.01% |
1,911
-490
| -20% | -$9.27K |
|
4867
PUT
Invesco CurrencyShares Swiss Franc Trust
FXF
$397M
| $39K | ﹤0.01% |
400
-300
| -43% | -$29.7K |
|
4868
MACOM Technology Solutions
MTSI
$19.3B
| $39K | ﹤0.01% |
1,187
-1,781
| -60% | -$67.5K |
|
4869
Phibro Animal Health
PAHC
$1.48B
| $39K | ﹤0.01% |
2,083
-8,228
| -80% | -$172K |
|
4870
Peoples Bancorp
PEBO
$1.49B
| $39K | ﹤0.01% |
1,790
+940
| +111% | +$19.7K |
|
4871
Q2 Holdings
QTWO
$3.91B
| $39K | ﹤0.01% |
+1,391
| New | +$34.8K |
|
4872
PUT
Zumiez
ZUMZ
$341M
| $39K | ﹤0.01% |
+2,700
| New | +$42.9K |
|
|
VIVO
4873
PUT
DELISTED
Meridian Bioscience Inc
VIVO
| $39K | ﹤0.01% |
2,000
+1,500
| +300% | +$29.4K |
|
|
RST
4874
DELISTED
ROSETTA STONE INC
RST
| $39K | ﹤0.01% |
5,000
+4,567
| +1,055% | +$34.7K |
|
|
AMRI
4875
PUT
DELISTED
Albany Molecular Research Inc
AMRI
| $39K | ﹤0.01% |
2,900
+900
| +45% | +$13.1K |
|
Similar funds
Barclays's Q2 2016 Portfolio in Review
As of Q2 2016, Barclays held 7,054 positions worth $76.9B, up 17% from $65.6B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Barclays deployed $9.16B of net new capital in Q2 2016, opening 709 new positions and adding to 2,754 existing holdings. Its largest new stake was S&P Global: 236,625 shares worth $25.4M.
By sector, the portfolio is most concentrated in Technology at 5.6% of assets, up from 5.5% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $995M trimmed.
- Barclays's largest Q2 2016 buy was S&P Global: 236,625 shares worth $25.4M.
- Barclays added most to McDonald's in Q2 2016, an estimated $376M increase.
- Barclays's biggest Q2 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $995M.
- Barclays fully exited CAMERON INTERNATIONAL CORPORATION in Q2 2016, selling an estimated $261M.
- Barclays's ten largest holdings make up 32% of its $76.9B portfolio in Q2 2016.
- Barclays opened 709 new positions and closed 569 in Q2 2016.
- Barclays's portfolio value rose 17% quarter-over-quarter to $76.9B.
Based on Barclays's 13F filing for Q2 2016, filed 12 Aug 2016.